Platelet Rich Fibrin in Soft Tissue Healing After Implant Uncovering
Evaluation of Healing Time and Postoperative Morbidity After Implant Uncovering With Vestibularly Repositioned Flap Associated With Leucocyte Platelet Rich Fibrin (L-PRF): a Randomized and Controlled Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
This study represents a prospective, controlled and randomized clinical trial assessing the effects of L-PRF on the healing time of the donor area and on the patient's postoperative morbidity in the 4 weeks following the Apically Positioned Flap (APF) procedure in the uncovering phase of two-stage implants. A total of 40 patients were recruited and divided into two groups. The implant uncovering procedure in the test group was performed with APF and application of L-PRF on the donor area. Patients in the control group, on the other hand, were treated with APF alone, leaving the donor area to heal by secondary intention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2021
CompletedFirst Submitted
Initial submission to the registry
May 10, 2022
CompletedFirst Posted
Study publicly available on registry
May 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2022
CompletedDecember 19, 2022
May 1, 2022
1.3 years
May 10, 2022
December 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complete re-epithelialization of the wound of donor area (CWE)
Time needed to obtain a complete re-epithelialization of the wound of donor area
4 weeks
Secondary Outcomes (4)
Post-Operative Discomfort (D)
4 weeks
Changes in Feedind Habits (CFH)
4 weeks
Consumption of Analgesics (AU)
4 weeks
Alteration of Sensivity (AS)
4 weeks
Study Arms (2)
APF + L-PRF
EXPERIMENTALApplication of a layer of L-PRF to protect the donor area after uncovering implant procedure using Apically Positioned Flap (APF).
APF without L-PRF
ACTIVE COMPARATORThe donor area is left to heal by secondary intention after APF in the implant uncovering procedure.
Interventions
After implant uncovering procedure with apically positioned flap, the donor area is covered with a layer of L-PRF
After implant uncovering procedure with apically positioned flap, the donor area is left to heal by secondary intention
Eligibility Criteria
You may qualify if:
- to have at least one implant in the maxilla with a quantity of vestibular keratinized gingiva \< 2 mm
- to be in good systemic health
- to have a good oral hygiene (FMPS and FMBS \< 20%)
You may not qualify if:
- systemic diseases: coagulation disorders; medications affecting periodontal status in the previous 6 months; pregnancy or lactation;
- smoking habits;
- peri-implant surgery on the experimental sites.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
G. D'Annunzio University
Chieti, 66100, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full time professor
Study Record Dates
First Submitted
May 10, 2022
First Posted
May 16, 2022
Study Start
April 20, 2021
Primary Completion
July 30, 2022
Study Completion
July 30, 2022
Last Updated
December 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share